Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

Kumiai Chemical Industry

クミアイ化学工業

4996 · TSE · Chemicals · 2 articles

Financials Consolidated

Revenue¥170bn+5.8% year on yearConsolidated · FY10/25

Ordinary profit¥13.4bn−27.0% year on yearConsolidated · FY10/25

Net profit¥4.38bn−67.8% year on yearConsolidated · FY10/25

Dividend per share¥24.00FY10/25

Performance over time

Revenue
¥118bnFY10/21
¥145bnFY10/22
¥161bnFY10/23
¥161bnFY10/24
¥170bnFY10/25
Ordinary profit
¥12.8bnFY10/21
¥23.6bnFY10/22
¥24.1bnFY10/23
¥18.3bnFY10/24
¥13.4bnFY10/25
Net profit (attributable)
¥9.02bnFY10/21
¥16.3bnFY10/22
¥18.0bnFY10/23
¥13.6bnFY10/24
¥4.38bnFY10/25
Op. cash flow
¥4.48bnFY10/21
−¥1.16bnFY10/22
¥4.76bnFY10/23
−¥16.7bnFY10/24
¥33.8bnFY10/25

People & pay

Employees, whole group2,153 peopleFY10/25

Employees, parent company (non-consolidated)799 peopleFY10/25

Average salary¥7.70mFY10/25

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitNet profit (attributable)EPSDividendTotal assetsNet assetsOp. cash flow
FY10/25¥170bn+5.8% year on year¥13.4bn¥4.38bn¥36.38¥24.00¥248bn¥151bn¥33.80bn
FY10/24¥161bn0.0% year on year¥18.3bn¥13.59bn¥112.91¥34.00¥275bn¥153bn−¥16.73bn
FY10/23¥161bn+10.8% year on year¥24.1bn¥18.02bn¥149.88¥45.00¥227bn¥140bn¥4.76bn
FY10/22¥145bn+23.0% year on year¥23.6bn¥16.33bn¥135.45¥22.00¥205bn¥122bn−¥1.16bn
FY10/21¥118bn¥12.8bn¥9.02bn¥72.13¥15.00¥169bn¥110bn¥4.48bn

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100XH23 · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:4996

Tokyo Brief coverage

  1. Generic Rivals Undercut Kumiai Chemical's Export Herbicide, Slashing Profit Guidance

    Kumiai Chemical now expects full-year sales of ¥175.0bn, up 8% from its December guidance, but has cut operating profit guidance 62.5% to ¥2.7bn after generic rivals crushed prices for one of its export herbicides and forced an inventory writedown, even as equity-method gains and yen-driven forex gains cushioned the ordinary-profit line and the dividend forecast stayed at ¥24 a share.

  2. Kumi Chemical raises first-half outlook, but special losses still weigh

    Kumi Chemical now expects first-half revenue of ¥102,900 million and operating profit of ¥10,400 million, well above its December forecast, citing pulled-forward agrochemical shipments and solid chemical-product sales. But a separate notice said a subsidiary's chlorination business will record a ¥514 million impairment and a ¥907 million structural reform cost in the February-to-April quarter. The company left its full-year outlook unchanged while assessing Middle East risks. So the operating story improved sharply, but reported profit still comes with attachments.

All articles loaded · 2 shown

Cross-holdings

Strategic shareholdings and sales, by fiscal year.

6 fiscal years · data through

Balance-sheet value
¥4.55bnFY10/21
¥4.72bnFY10/22
¥4.87bnFY10/23
¥4.78bnFY10/24
¥5.41bnFY10/25
Sale proceeds
¥2.47bnFY10/21
—FY10/22
—FY10/23
—FY10/24
¥0.30bnFY10/25

Balance-sheet value is the reporting company's own listed holdings (its largest holding subsidiary's where marked), carried at market value; the percentage divides it by consolidated net assets in the same annual report.

Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 Oct 202514¥5.41bn3.58%1¥302mFiled  — filing S100XH23
Show 5 more fiscal years (6 total)
Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 Oct 202415¥4.78bn3.13%——Filed  — filing S100V5BU
31 Oct 202315¥4.87bn3.48%——Filed  — filing S100SNSO
31 Oct 202215¥4.72bn3.87%——Filed  — filing S100Q0EI
31 Oct 202115¥4.55bn4.14%1¥2.47bnFiled  — filing S100N9S1
31 Oct 202016¥6.56bn6.31%1¥26mFiled  — filing S100KKG0

Fund positioning

Current holdings disclosed by tracked funds.

23 funds · data through

Held by 23 tracked funds; largest weight 0.10%. Holdings as of 31 Jul 2026–20 Nov 2026.

Show 13 more funds (23 total)